5-HT1A receptor binding levels in the cerebral cortex and amygdala were lower in both PD and AD patients [19–21], and in the AD patients, its levels of the cerebral cortex were negatively associated with the severity of dementia [20]. The gene discussed is HTR1A; the disease is Alzheimer disease.